Patent · US Active

Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof

US10428053B2 · kind B2 · utility

3Cited by
14References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2016
Grant dateOct 1, 2019
Priority date
Expiry dateSep 15, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.